Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 2
Submit an article Journal homepage
1,644
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Knocking down Sterol regulatory element binding protein 2 (SREBF2) inhibits the Serine Protease 8 (PRSS8) /sodium channel epithelial 1alpha subunit (SCNN1A) axis to reduce the cell proliferation, migration and epithelial-mesenchymal transformation of ovarian cancer

Chunyan CaiDepartment of Gynaecology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, China
,
Yumei ZhangDepartment of Gynaecology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, China
&
Xing PengDepartment of Gynaecology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University, Huai’an, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5553-2045
ORCID Icon
Pages 9390-9400 | Received 18 May 2021, Accepted 04 Sep 2021, Published online: 25 Nov 2021

References

  • Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3–14. PubMed PMID: 27743768
  • Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151–156. PubMed PMID: 30867104
  • Tamir A, Gangadharan A, Balwani S, et al. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer. J Ovarian Res. 2016;9(1):20. PubMed PMID: 27036110; PubMed Central PMCID: PMCPMC4815131
  • Sun G, Qin J, Qiu Y, et al. Microarray analysis of gene expression in the ovarian cancer cell line HO-8910 with silencing of the ZNF217 gene. Mol Med Rep. 2009;2(5):851–855. PubMed PMID: 21475912
  • Fazio S, Berti G, Russo F, et al. The miR-28-5p targetome discovery identified SREBF2 as one of the mediators of the miR-28-5p tumor suppressor activity in prostate cancer cells. Cells. 2020;9(2):354. PubMed PMID: 32028704; PubMed Central PMCID: PMCPMC7072282
  • Wen Y-A, Xiong X, Zaytseva YY, et al. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis. 2018;9(3):265. PubMed PMID: 29449559; PubMed Central PMCID: PMCPMC5833501
  • Zheng L, Li L, Lu Y, et al. SREBP2 contributes to cisplatin resistance in ovarian cancer cells. Exp Biol Med (Maywood). 2018;243(7):655–662. PubMed PMID: 29466876; PubMed Central PMCID: PMCPMC6582395
  • Chien SY, Tsai CH, Liu SC, et al. Noggin Inhibits IL-1beta and BMP-2 expression, and attenuates cartilage degeneration and subchondral bone destruction in experimental osteoarthritis. Cells. 2020;9(4):927. PubMed PMID: 32290085; PubMed Central PMCID: PMCPMC7226847
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. PubMed PMID: 11846609
  • Zhang Y, Huang J, Li X, et al. Identification of functional transcriptional binding sites within chicken Abcg2 gene promoter and screening its regulators. Genes (Basel). 2020;11(2). DOI:10.3390/genes11020186. PubMed PMID: 32050731; PubMed Central PMCID: PMCPMC7073639
  • Giampaolino P, Della Corte L, Foreste V, et al. Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer. Minerva Med. 2019;110(4):279–291. PubMed PMID: 31081307
  • Bao Y, Guo Y, Yang Y, et al. PRSS8 suppresses colorectal carcinogenesis and metastasis. Oncogene. 2019;38(4):497–517. PubMed PMID: 30115975
  • Zhang L, Jia G, Shi B, et al. PRSS8 is downregulated and suppresses tumour growth and metastases in hepatocellular carcinoma. Cell Physiol Biochem. 2016;40(3–4):757–769. PubMed PMID: 27915333
  • Eid W, Dauner K, Courtney KC, et al. mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells. Proc Natl Acad Sci U S A. 2017;114(30):7999–8004. PubMed PMID: 28696297; PubMed Central PMCID: PMCPMC5544314
  • Casella C, Miller DH, Lynch K, et al. Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells. Gynecol Oncol. 2014;135(2):333–341. PubMed PMID: 25134999; PubMed Central PMCID: PMCPMC5516475
  • Huang Y, Zhang J, Shao H, et al. miR-33a mediates the anti-tumor effect of lovastatin in osteosarcoma by targeting CYR61. Cell Physiol Biochem. 2018;51(2):938–948. PubMed PMID: 30466075
  • Wu L, Ling ZH, Wang H, et al. Upregulation of SCNN1A promotes cell proliferation, migration, and predicts poor prognosis in ovarian cancer through regulating epithelial-mesenchymal transformation. Cancer Biother Radiopharm. 2019;34(10):642–649. PubMed PMID: 31549859

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.